Krishnan Suma sold KRYS
September 4, 2026 · Form 4 insider transaction
Krishnan Suma sold 2,320 shares of Krystal Biotech, Inc. at $360.47 per share, a transaction worth $836.3K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 0 days after the transaction.
Direction
Disposed (sell-side)
Shares
2,320
Price
$360.47
Total value
$836.3K
InsiderKrishnan Suma
Role—
CompanyKrystal Biotech, Inc. (KRYS)
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 4, 2026
Filing dateSeptember 4, 2026
Shares owned after1,308,498
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
The transaction was executed in multiple trades ranging from $360.01 to $361.005. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth herein.